Home | Business News | Browse by Publication | P | Pharma Marketletter

CollaGenex denied motion to prevent generic Periostat.

Publication: Pharma Marketletter
Publication Date: 11-JUL-05
Format: Online
Delivery: Immediate Online Access
Full Article Title: CollaGenex denied motion to prevent generic Periostat.(CollaGenex Pharmaceuticals Inc.)(Brief Article)

Article Excerpt
CollaGenex Pharmaceuticals of the USA says that its motion seeking a temporary restraining order and a preliminary injunction in the US District Court for the Eastern District of New York had been denied.

As a result, the defendants IVAX Pharmaceuticals and CorePharma LLC can continue to market their copycat...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Myriad acquires patent on key AD protein: AB42.(Myriad Genetics Inc.)(..., July 11, 2005
French Pharma makes contribution to reform., July 11, 2005
GlaxoSmithKline to debut five vaccines with market value of up to $18 ..., July 11, 2005
Procyon concludes Bioxalis Medica buy.(Brief Article), July 11, 2005
Organon launches global research and biotech initiative.(Brief Article..., July 11, 2005

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.